Stay updated on Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:03.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.1, replacing v3.4.0, with no changes to study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T04:43:26.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page's Locations section was reorganized into a single 'Locations' block with an expanded list of sites across multiple regions, replacing the prior country/state location headers. The update also includes Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-24T14:38:05.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    Publications section updated with clarifications that publications are provided voluntarily by the study entry author and are auto-filled from PubMed; the Revision: v3.3.2 note is now shown.
    Difference
    0.1%
    Check dated 2025-11-24T17:08:49.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page; the rest of the study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:05:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in cSCC: Recurrent/Metastatic Clinical Trial page.